Wei S - Search Results

1

Novel loss-of-function mutation in BRCA2 gene identified in a Chinese female with a family history of ovarian cancer: A case report.

Cui Y, Wang Y, Zhang N, He J, Huang H, Liu F, Wei S, Dong Q, Wu J, Lin K, Chen W, Xiang J, Jin H, Peng Z, Zhao Q, Li W, Jiang D, Banerjee S. Cui Y, et al. Among authors: wei s. Oncol Lett. 2019 Mar;17(3):3350-3354. doi: 10.3892/ol.2019.9950. Epub 2019 Jan 21. Oncol Lett. 2019. PMID: 30867769 Free PMC article.

2

LncRNA PTCSC3 Inhibits Tumor Growth and Cancer Cell Stemness in Gastric Cancer by Interacting with lncRNA Linc-pint.

Hong L, Wang H, Wang J, Wei S, Zhang F, Han J, Liu Y, Ma M, Liu C, Xu Y, Jiang D. Hong L, et al. Among authors: wei s. Cancer Manag Res. 2019 Dec 11;11:10393-10399. doi: 10.2147/CMAR.S231369. eCollection 2019. Cancer Manag Res. 2019. PMID: 31849528 Free PMC article.

3

Novel mutation signatures in the prognosis of EGFR-TKIs targeted therapy for non-small cell lung cancer patients based on the 1000-gene panel sequencing.

Zhang H, Jiang D, Jin H, Cui YZ, Wei SJ, Li Y, Dong Q, Zuo J, Tian CJ, Yan F, Wang XW. Zhang H, et al. Neoplasma. 2022 Mar;69(2):352-360. doi: 10.4149/neo_2021_210914N1307. Epub 2022 Jan 28. Neoplasma. 2022. PMID: 35081725

4

[Research Progress of KRAS Mutation in Non-small Cell Lung Cancer].

Liu L, Wei S. Liu L, et al. Among authors: wei s. Zhongguo Fei Ai Za Zhi. 2018 May 20;21(5):419-424. doi: 10.3779/j.issn.1009-3419.2018.05.11. Zhongguo Fei Ai Za Zhi. 2018. PMID: 29764594 Free PMC article. Review. Chinese.

5

Genomic alteration profiles of lung cancer and their relationship to clinical features and prognosis value using individualized genetic testing.

Zhang F, Wang J, Ma M, Xu Y, Lu X, Wei S. Zhang F, et al. Among authors: wei s. J Thorac Dis. 2021 Aug;13(8):5007-5015. doi: 10.21037/jtd-21-1031. J Thorac Dis. 2021. PMID: 34527339 Free PMC article.

6

A patient with advanced lung squamous cell carcinoma who failed to benefit from albumin bound paclitaxel plus pembrolizumab achieved partial response with second-line treatment of docetaxel plus pembrolizumab: a case report.

Zhang F, Xu Y, Guo S, Li S, Ma K, Wang J, Wei S. Zhang F, et al. Among authors: wei s. Ann Palliat Med. 2022 Sep;11(9):3020-3027. doi: 10.21037/apm-22-960. Ann Palliat Med. 2022. PMID: 36217630 Free article.

7

Association between baseline C‑reactive protein level and survival outcomes for cancer patients treated with immunotherapy: A meta‑analysis.

Xu Y, Ma K, Zhang F, Ma M, Hong L, Wang J, Li S, Sun P, Wang J, Wei S. Xu Y, et al. Among authors: wei s. Exp Ther Med. 2023 Jun 8;26(2):361. doi: 10.3892/etm.2023.12060. eCollection 2023 Aug. Exp Ther Med. 2023. PMID: 37408861 Free PMC article.

8

[Analysis of the factors associated with abnormal coagulation and prognosis  in patients with non-small cell lung cancer].

Li Y, Wei S, Wang J, Hong L, Cui L, Wang C. Li Y, et al. Among authors: wei s. Zhongguo Fei Ai Za Zhi. 2014 Nov;17(11):789-96. doi: 10.3779/j.issn.1009-3419.2014.11.04. Zhongguo Fei Ai Za Zhi. 2014. PMID: 25404269 Free PMC article. Chinese.

9

[Advances on mechanisms of coagulation with non-small cell lung cancer].

Li Y, Wei S. Li Y, et al. Among authors: wei s. Zhongguo Fei Ai Za Zhi. 2013 Dec;16(12):676-80. doi: 10.3779/j.issn.1009-3419.2013.12.11. Zhongguo Fei Ai Za Zhi. 2013. PMID: 24345495 Free PMC article. Review. Chinese.

10

CircRNA_0000429 Regulates Development of NSCLC by Acting as a Sponge of miR-1197 to Control MADD.

Wang JY, Zhang F, Hong L, Wei SJ. Wang JY, et al. Cancer Manag Res. 2021 Jan 29;13:861-870. doi: 10.2147/CMAR.S270790. eCollection 2021. Cancer Manag Res. 2021. PMID: 33542659 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,310 results

Search Page

Filters